HUEMOELLER JOHN WALTER II 4
4 · AXIM BIOTECHNOLOGIES, INC. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
HUEMOELLER JOHN WALTER II
Director
Transactions
- Award
Convertible Note
2024-03-15$250000.00/sh+1$250,000→ 42,500,000 totalExercise: $0.02From: 2024-03-15Exp: 2034-03-01→ Common Stock (12,500,000 underlying)
Footnotes (1)
- [F1]Reporting Person acquired a convertible note, face value $250,000. The note is convertible into shares of Issuer's common stock at a price of $0.02 per share.